Literature DB >> 22468174

Acrodermatitis continua of hallopeau successfully treated with adalimumab.

Jennifer A Sopkovich, Georgann Anetakis Poulos, Henry K Wong.   

Abstract

Acrodermatitis continua of Hallopeau, first described by Hallopeau in 1890, is an uncommon variant of pustular psoriasis. Acrodermatitis continua of Hallopeau presents as sterile pustules on the hands and feet. It has a relapsing course. Although acrodermatitis continua of Hallopeau is a pustular psoriasis variant, the condition is not easily treated with antipsoriatic medications. In the following case, the authors report a case of acrodermatitis continua of Hallopeau successfully treated with adalimumab. In addition, the cases of acrodermatitis continua of Hallopeau treated with tumor necrosis-alpha inhibitors are summarized.

Entities:  

Year:  2012        PMID: 22468174      PMCID: PMC3315880     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  13 in total

1.  Etanercept and recalcitrant acrodermatitis continua of Hallopeau.

Authors:  Arjen F Nikkels; Gérald E Piérard
Journal:  J Drugs Dermatol       Date:  2006-09       Impact factor: 2.114

2.  Acrodermatitis continua of Hallopeau responding to efalizumab therapy.

Authors:  N Balato; L Gallo; A Balato; S La Bella; F Ayala
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-02-23       Impact factor: 6.166

3.  Excellent and prolonged response to infliximab in a case of recalcitrant acrodermatitis continua of Hallopeau.

Authors:  C Rubio; M A Martin; D M Arranz Sánchez; C Vidaurrazaga; M Casado
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-09-09       Impact factor: 6.166

Review 4.  Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.

Authors:  Lluís Puig; Didac Barco; Eva Vilarrasa; Agustín Alomar
Journal:  Dermatology       Date:  2010-01-26       Impact factor: 5.366

5.  Etanercept responsive acrodermatitis continua of Hallopeau: is a pattern developing?

Authors:  Brian Bonish; Rashid M Rashid; James Swan
Journal:  J Drugs Dermatol       Date:  2006-10       Impact factor: 2.114

6.  The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau.

Authors:  Kimberly Kazinski; Kathleen M Joyce; Darryl Hodson
Journal:  J Drugs Dermatol       Date:  2005 May-Jun       Impact factor: 2.114

7.  Successful treatment of acrodermatitis continua of Hallopeau by the tumour necrosis factor-alpha inhibitor infliximab (Remicade).

Authors:  R Mang; T Ruzicka; H Stege
Journal:  Br J Dermatol       Date:  2004-02       Impact factor: 9.302

8.  Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade).

Authors:  A-M Thielen; C Barde; G Marazza; J-H Saurat
Journal:  Dermatology       Date:  2008-05-26       Impact factor: 5.366

9.  Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau.

Authors:  Elke Weisshaar; Thomas L Diepgen
Journal:  J Dtsch Dermatol Ges       Date:  2007-06       Impact factor: 5.584

10.  Successful treatment of a 9-year-old boy affected by acrodermatitis continua of Hallopeau with targeted ultraviolet B narrow-band phototherapy.

Authors:  Matteo Bordignon; Edoardo Zattra; Cristiana Albertin; Anna Belloni-Fortina
Journal:  Photodermatol Photoimmunol Photomed       Date:  2010-02       Impact factor: 3.135

View more
  3 in total

1.  Successful treatment of Acrodermatitis continua of Hallopeau associated with psoriatic arthritis with adalimumab.

Authors:  Salima Lefkir; Samy Slimani; Nadjia Brahimi; Aicha Ladjouze-Rezig
Journal:  Eur J Rheumatol       Date:  2015-03-31

Review 2.  Autoinflammatory pustular neutrophilic diseases.

Authors:  Haley B Naik; Edward W Cowen
Journal:  Dermatol Clin       Date:  2013-06-02       Impact factor: 3.478

3.  Acrodermatitis continua of Hallopeau: clinical perspectives.

Authors:  Mary Patricia Smith; Karen Ly; Quinn Thibodeaux; Tina Bhutani; Wilson Liao; Kristen M Beck
Journal:  Psoriasis (Auckl)       Date:  2019-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.